Verrica Pharmaceuticals (VRCA)

• Market cap: $44.9M
• 1 day: -3.85%
• 5 days: -7.41%
• 1 month: -30.35%
• 3 months: -29.53%
• 6 months: -20.7%
• Year to date: -32.43%
• 1 year: -75.52%
• 5 years: -94.62%
• 10 years: -97.29%
• Sector: Healthcare
• Industry: Biotechnology

About: Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Employees: 71

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

3% more capital invested

Capital invested by funds: $13M [Q1] → $13.4M (+$397K) [Q2]

0.52% less ownership

Funds ownership: 3.21% [Q1] → 2.69% (-0.52%) [Q2]

23% less funds holding

Funds holding: 74 [Q1] → 57 (-17) [Q2]

50% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 22

57% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 30